US biotech company Abraxis BioScience has launched its innovative breast cancer treatment Abraxane in Europe. The drug is a variant …
Bristol Myers Squibb has denied claims it is making a further 10% reduction to its work force, and said any …
A review of the NHS in 2008 NHS-pharma collaborations come of ageIn January, new guidelines were agreed to help NHS …
The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …
Patient power proves decisive in battle for accessSocial networking helped a new breed of informed patient advocates win the …
Pfizer could be preparing itself to buy Amgen to maintain its lead in the sector, according to a leading analyst. …

How did you find your way into your current role?After graduating, I worked as a clinical dietitian for the NHS …
Bayer has called for more tax breaks to support research and development in Germany.The company has urged the German government …
Pfizer is to cut its workforce in France by axeing 700 jobs in order to reduce costs and counteract patent …
Few things more graphically illustrate the conservative nature of pharma marketers than the slow birth of e-detailing. Ten years ago, …
Bristol-Myers Squibb is to cut its global workforce by an extra 10% before 2010, in order to reduce costs and …
Healthcare specialist Tonic Life Communications has boosted its UK business with the appointment of a new managing director.Neil Flash, formerly …
The NHS is building an online portal to store drug information in one place.NHS Evidence will pool clinical data for …
Lilly aims to reduce the cost of it bringing new molecules to market by a third.The company's goal is to …
A number of pharmaceutical companies in the US have recently announced they will declare all the payments to healthcare professionals. …
Is UK pharma coping with the revised Code and what changes will 2009 bring?
One of Barack Obama's key goals as president is to reduce healthcare costs, particularly those related to prescription medications, by …
Sanofi-Aventis' head of finance and legal affairs Jean-Claude Leroy is to leave the company as new chief executive Chris Viehbacher …
The Conservatives have led in the opinion polls throughout 2008, and even with Gordon Brown’s rating enjoying a bounce over …